Long term current) use of tofacitinib
Z79.622
Z79.622 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10-CM Z79.622 is a new 2023 ICD-10-CM code that became effective on October 1, 2022.
This is the American ICD-10-CM version of Z79.622 – other international versions of ICD-10 Z79.622 may differ.